{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2016-D-4308\" sorted by posted_date descending", "rows": [["FDA-2016-D-4308-0032", "FDA", "FDA-2016-D-4308", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-02-11T05:00:00Z", 2019, 2, "2019-02-11T05:00:00Z", null, "2019-02-11T12:59:41Z", "2019-01812", 0, 0, "0900006483a5e832"], ["FDA-2016-D-4308-0026", "FDA", "FDA-2016-D-4308", "04 Reference 3 Compliance Program Guidance Manual Chapter 42 Blood and Blood Components Inspection of Licensed and Unlicensed Blood Banks Brokers Reference Laboratories and Contractors", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:36:48Z", null, 0, 0, "09000064839beb23"], ["FDA-2016-D-4308-0023", "FDA", "FDA-2016-D-4308", "01 RBC Antigen_Reference List", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:34:03Z", null, 0, 0, "09000064839beb20"], ["FDA-2016-D-4308-0022", "FDA", "FDA-2016-D-4308", "Labeling of Red Blood Cell Units with Historical Antigen Typing Results; Guidance for Industry", "Other", "Guidance", "2018-12-21T05:00:00Z", 2018, 12, "2018-12-21T05:00:00Z", null, "2024-11-12T22:52:35Z", null, 1, 0, "09000064839beb1e"], ["FDA-2016-D-4308-0021", "FDA", "FDA-2016-D-4308", "Labeling of Red Blood Cell Units With Historical Antigen Typing Results;\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2018-12-21T05:00:00Z", 2018, 12, "2018-12-21T05:00:00Z", null, "2018-12-21T14:24:57Z", "2018-27654", 0, 0, "09000064839be0a5"], ["FDA-2016-D-4308-0028", "FDA", "FDA-2016-D-4308", "06 Reference 5 AABB Standards for Blood Banks and Transfusion Services 30th edition", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:38:11Z", null, 0, 0, "09000064839beb25"], ["FDA-2016-D-4308-0029", "FDA", "FDA-2016-D-4308", "07 Reference 6 FDA Guidance for Industry Computer Crossmatch Computerized Analysis of the Compatibility between the Donors Cell Type and the Recipients Serum or Plasma Type April 2011", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:39:29Z", null, 0, 0, "09000064839be828"], ["FDA-2016-D-4308-0027", "FDA", "FDA-2016-D-4308", "05 Reference 4 Blood Product Advisory Committee Meeting Transcripts_ Dec 4 2012", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:37:26Z", null, 0, 0, "09000064839beb24"], ["FDA-2016-D-4308-0031", "FDA", "FDA-2016-D-4308", "09 Reference 8 FDA Guidance for Industry Availability of FDAs e_Submitter Program for Regulatory Submissions from Licensed Blood Establishments August 2011", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:40:39Z", null, 0, 0, "09000064839be82a"], ["FDA-2016-D-4308-0025", "FDA", "FDA-2016-D-4308", "03 Reference 2 Poole J Daniels G Blood group antibodies and their significance in transfusion medicine Transfus Med Rev 2007 21_58_71", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:36:02Z", null, 0, 0, "09000064839beb22"], ["FDA-2016-D-4308-0024", "FDA", "FDA-2016-D-4308", "02 Reference 1 Daniels G Reid ME Blood groups the past 50 years Transfusion 2010 Feb 50_2_281_9", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:35:17Z", null, 0, 0, "09000064839beb21"], ["FDA-2016-D-4308-0030", "FDA", "FDA-2016-D-4308", "08 Reference 7 FDA Guidance for Industry Submission of CMC and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion or for Further Manufacture", "Supporting & Related Material", "Background Material", "2018-12-21T05:00:00Z", 2018, 12, null, null, "2018-12-21T14:40:04Z", null, 0, 0, "09000064839be829"], ["FDA-2016-D-4308-0020", "FDA", "FDA-2016-D-4308", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Draft Guidance for\nIndustry: Labeling of Red Blood Cell Units With Historical Antigen Typing\nResults", "Notice", "30 Day Proposed Information Collection", "2018-10-22T04:00:00Z", 2018, 10, "2018-10-22T04:00:00Z", "2018-11-22T04:59:59Z", "2018-10-22T18:26:51Z", "2018-22959", 0, 0, "0900006483837d3f"], ["FDA-2016-D-4308-0008", "FDA", "FDA-2016-D-4308", "Reference 5 Blood Product Advisory ommittee Meeting Transcripts_ Dec 4 2012 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:13:53Z", null, 0, 0, "0900006482446f1b"], ["FDA-2016-D-4308-0011", "FDA", "FDA-2016-D-4308", "09 Reference 8 FDA Guidance for Industry Computer Crossmatch Computerized Analysis of the Compatibility between the Donors Cell Type and the Recipients Serum or Plasma Type April 2011 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:14:06Z", null, 0, 0, "0900006482446f1e"], ["FDA-2016-D-4308-0004", "FDA", "FDA-2016-D-4308", "Reference 1 Daniels G Reid ME Blood groups the past 50 years Transfusion 2010 Feb 50_2_281_9 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:13:38Z", null, 0, 0, "0900006482446e45"], ["FDA-2016-D-4308-0012", "FDA", "FDA-2016-D-4308", "10 Reference 9 FDA Guidance for Industry For the Submission of Chemistry Manufacturing and Controls and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:14:09Z", null, 0, 0, "0900006482446f1f"], ["FDA-2016-D-4308-0005", "FDA", "FDA-2016-D-4308", "Reference 2 Poole J Daniels G Blood group antibodies and their significance in transfusion medicine Transfus Med Rev 2007 21_58_71 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:13:41Z", null, 0, 0, "0900006482446f18"], ["FDA-2016-D-4308-0001", "FDA", "FDA-2016-D-4308", "Labeling of Red Blood Cell Units With Historical Antigen Typing Results;\nDraft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2017-01-03T05:00:00Z", 2017, 1, "2017-01-03T05:00:00Z", null, "2017-01-03T14:44:35Z", "2016-31771", 0, 0, "0900006482445ef6"], ["FDA-2016-D-4308-0003", "FDA", "FDA-2016-D-4308", "RBC Antigen Reference List re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:13:34Z", null, 0, 0, "0900006482446e44"], ["FDA-2016-D-4308-0006", "FDA", "FDA-2016-D-4308", "Reference 3 Compliance Program Guidance Manual Chapter 42  Blood and Blood Components Inspection of Licensed and Unlicensed Blood Banks Brokers Reference Laboratories and Contractors 7342_001 dated Jun 1 16 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:13:44Z", null, 0, 0, "0900006482446f19"], ["FDA-2016-D-4308-0010", "FDA", "FDA-2016-D-4308", "Reference 7 FDA Guidance for Industry Biological Product Deviation Reporting for Blood and Plasma Establishments October 2006 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:14:03Z", null, 0, 0, "0900006482446f1d"], ["FDA-2016-D-4308-0009", "FDA", "FDA-2016-D-4308", "Reference 6 AABB Standards for Blood Banks and Transfusion Services 30th edition re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:13:59Z", null, 0, 0, "0900006482446f1c"], ["FDA-2016-D-4308-0002", "FDA", "FDA-2016-D-4308", "Labeling of Red Blood Cell Units with Historical Antigen Typing Results\nDraft Guidance for Industry", "Other", "Guidance", "2017-01-03T05:00:00Z", 2017, 1, "2017-01-03T05:00:00Z", "2017-04-04T03:59:59Z", "2024-11-07T23:52:00Z", null, 1, 0, "0900006482446e42"], ["FDA-2016-D-4308-0007", "FDA", "FDA-2016-D-4308", "Reference 4 AABB_FDA Liaison Meeting April 12 2012 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:13:50Z", null, 0, 0, "0900006482446f1a"], ["FDA-2016-D-4308-0013", "FDA", "FDA-2016-D-4308", "Reference 10 FDA Guidance for Industry Availability of FDAs e_Submitter Program for Regulatory Submissions from Licensed Blood Establishments August 2011 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry", "Supporting & Related Material", "Background Material", "2017-01-03T05:00:00Z", 2017, 1, null, null, "2017-01-03T15:14:12Z", null, 0, 0, "0900006482446f20"]], "truncated": false, "filtered_table_rows_count": 26, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2016-D-4308"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-D-4308", "results": [{"value": "FDA", "label": "FDA", "count": 26, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-D-4308", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 20, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-D-4308", "results": [{"value": 2017, "label": 2017, "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&posted_year=2017", "selected": false}, {"value": 2018, "label": 2018, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&posted_year=2018", "selected": false}, {"value": 2019, "label": 2019, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&posted_year=2019", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-D-4308&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 78.57383997179568, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}